Lorusso, R, Matteucci, M, Ronco, D, Massimi, G, Price, S, Czerny, M, Estévez-Loureiro, R, Siepe, M, Pontone, G, Hassager, C, Chioncel, O, Zuin, M, Davos, CH, Adamo, M, Gustafsson, F, Giannakoulas, G, Amabile, N, Sionis, A, Thielmann, M, Petersen, SE, Cosyns, B, Huber, K, Tokmakova, M, Pacini, D, Klok, FA, Saia, F, Abreu, A, Grimm, M, Claeys, MJ, García-Alvarez, A, Gerber, B, Mestres, CA, Rosenkranz, S, Adamopoulos, S, Bonaros, N. Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarction: A clinical consensus statement of the ESC Working Group on Cardiovascular Surgery, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, the ESC Working Group on Pulmonary Circulation and Right Ventricular Function, the European Association of Preventive Cardiology of the ESC, the Heart Failure Association of the ESC, the European Association of Cardiovascular Imaging of the ESC, and the European Association for Cardio-Thoracic Surgery. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2026; 68(5)DOI:10.1093/ejcts/ezag157. PMID:42112794. IF:3.000(Q1/2D).

Palazzini, M, Lehtonen, J, Potena, L, Mäyränpää, M, Rågback, J, Foà, A, Uribarri, A, Thiele, H, Vidal-burdeus, M, Freund, A, Gustafsson, F, Tschöpe, C, Elsanhoury, A, Ihle, J, Rudi, W, Grabmaier, U, Merlo, M, Melenovsky, V, Weislova, I, Jellinghaus, S, Linke, A, Baldovini, C, Adorisio, R, Kuchynka, P, Palecek, T, Krejcí, J, Poloczková, H, Caterino, A, Gilotra, N, Lovell, J, Macomb, E, Shih, J, Hong, K, Rossi, V, Ruschitzka, F, Cavallini, C, Riccini, C, Kamal, M, Huang, F, Groh, M, Gentile, P, Andrea, G, Lala, A, Shimokawa, H, Vandenbriele, C, Sionis, A, Schmidt, M, Grosu, A, Bollano, E, Turco, A. EOSINOPHILIC MYOCARDITIS INTERNATIONAL REGISTRY. EUROPEAN HEART JOURNAL SUPPLEMENTS. 2026; 28DOI:10.1093/eurheartjsupp/suag058.401. PMID:. IF:2.500(Q2/5D).

Ramos-Regaladoa, L, Schoch, L, Alcovera, S, Magaldi, M, Barriusoa, I, Padróa, T, Borrella, M, Badimona, L, Zaragozad, C, Vilahura, G. Differential regulation of the HIF-1«/apoptosis axis by miR-126-5p in cardiac cells during ischemia/reperfusion injury. Clinica E Investigacion En Arteriosclerosis. 2026; 38(3)DOI:10.1016/j.arteri.2025.500842. PMID:40816967. IF:(Q/D).

Reis, A, Araújo, ARD, Dias, IH, Antonny, B, Perez, A, Sánchez-Quesada, JL, de Freitas, V. Effect of type-2 diabetes on surface lipids and biophysical properties in lipoprotein populations. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2026; 779DOI:10.1016/j.abb.2026.110780. PMID:41780664. IF:3.000(Q2/4D).

Bellofatto, IA, Nikolaou, PE, Andreadou, I, Canepa, M, Carbone, F, Ghigo, A, Heusch, G, Kleinbongard, P, Maack, C, Podesser, BK, Stamatelopoulos, K, Stellos, K, Vilahur, G, Montecucco, F, Liberale, L. Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?. Clinical Research in Cardiology. 2026; 115(5)DOI:10.1007/s00392-024-02522-2. PMID:39167195. IF:3.700(Q1/3D).

Dobrosavljevic, M, Landén, M, Brikell, I, Chang, Z, Kuja-Halkola, R, Lichtenstein, P, Andell, P, Andreassen, OA, Bauer, M, Corcoy, R, De Girolamo, G, Reif, A, Larsson, H, Garcia-Argibay, M. A five-year risk prediction model of cardiovascular disease in individuals with bipolar disorder: a nationwide register study from Sweden. MOLECULAR PSYCHIATRY. 2026; 31(5)DOI:10.1038/s41380-025-03381-7. PMID:41420114. IF:10.100(Q1/1D).

Miñambres, I, Pérez, A. Lipid prevention in type 1 diabetes: From estimated risk to cumulative risk. Clinica E Investigacion En Arteriosclerosis. 2026; 38(3)DOI:10.1016/j.arteri.2026.500894. PMID:41690856. IF:(Q/D).

de Lapiscina, IM, Baquero, C, Santos, A, Molina, AR, Moure, MD, Aramburu, M, Bancalari, R, Boronat, M, Bueno, G, Casano-Sancho, P, Fernandez-Ramos, C, Garcia-Garcia, E, Gonzalez, A, Gonzalez-Rivera, N, Guerrero-Fernandez, J, Hernandez, MI, Paja, M, Portillo, N, Rica, I, Soto-Moreno, A, Suarez-Ortega, L, Vela, A, Castaño, L, Valdes, N. Prevalence of germline variants in USP8, USP48, CABLES1 and PAM in patients with pituitary adenomas. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2026; 194(5)DOI:10.1093/ejendo/lvag074. PMID:42045809. IF:5.200(Q1/2D).

Garcia-Pagan, JC, Gluud, LL, Mandorfer, M, Schattenberg, JM, De Gottardi, A, Berzigotti, A, Fortea, JI, Martínez, AA, Alvarado-Tapias, E, Berning, M, Petryszyn, P, Henricson, E, Berglind, N, Lin, M, Persson, K, Mercier, A, Ambery, P, Bosch, J, Oscarsson, J, Rockey, DC. Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; 92(5)DOI:10.1002/bcp.70332. PMID:41362018. IF:3.000(Q2/4D).

Scaramella, L, Cosenza, A, Romero-Mascarell, C, Elli, L. Antithrombotic and management of small bowel bleeding - time to throw caution into the wind?. CURRENT OPINION IN GASTROENTEROLOGY. 2026; 42(3)DOI:10.1097/MOG.0000000000001160. PMID:41700996. IF:2.500(Q2/5D).

Izarra, A, Bermúdez-López, M, Valdivielso, JM, Pamplona, R, Torres, G, Mauricio, D, Castro-Boqué, E, Fernández, E, Simó, R, Hernández, C, Lecube, A. Baseline and 4-year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort. DIABETES OBESITY & METABOLISM. 2026; 28(5)DOI:10.1111/dom.70560. PMID:41705635. IF:5.700(Q1/2D).

Dingemans, AMC, Opitz, I, Brunelli, A, Remon, J, Hendriks, LE, Edwards, J, Faivre-Finn, C, Reguart, N, Smit, EF, Levy, A, Sanchez-Lorente, D, Trujillo, JC, Filippi, AR, Stathopoulos, K, Blum, TG, Guckenberger, M, Popat, S, De Angelis, R, Hofman, P, von der Thüsen, J, Hartemink, KJ, Petersen, RH, Ruffini, E, Dickhoff, C, Houda, I, Prisciandaro, E, De Ruysscher, D, Derks, J, Bahce, I, Mariolo, A, Besse, B, Xenophontos, E, Levra, NG, van Schil, P, Brandao, M, Berghmans, T. Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration. Lancet Respiratory Medicine. 2026; 14(5)DOI:10.1016/S2213-2600(26)00051-2. PMID:41895314. IF:32.800(Q1/1D).

Scheffer, IE, Perry, MS, Sullivan, J, Boronat, S, Wheless, J, Brunklaus, A, Laux, L, Patel, AD, Roberts, C, Dlugos, D, Holder, D, Knupp, K, Lallas, M, Phillips, S, Segal, E, Lal, D, Wirrell, E, Zuberi, SM, Shaffer, R, Wojnaroski, M, Berl, MM, Christensen, S, James, ES, Vila, MC, Huang, N, Gofshteyn, JS, Rico, S. Characterizing early behavioral and social-emotional problems in young children with SCN1A+Dravet syndrome: Findings from the ENVISION prospective natural history study. EPILEPSIA. 2026; 67(5)DOI:10.1002/epi.70127. PMID:41627953. IF:6.600(Q1/1D).

Ibañez-Samaniego, L, Alonso, S, Cagigal, ML, Catalina, MV, Rodriguez, DR, Peligros, MI, Puente, A, Collado, AS, Téllez, L, Herrera, EL, Alvarado-Tapias, E, Iruzubieta, P, Loste, MTA, Fabrega, E, Cuadrado, A, Lafarga, M, Fortea, J. Ultrastructural analysis of transjugular biopsies in metabolic dysfunction-associated steatotic liver disease identifies core hepatocellular stress adaptations. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Fajol, MC, Brujats, A, Poca, M, Villanueva, C, Bataller, R, Gomariz, V, Ferrero, A, Alvarado-Tapias, E. Glucagon-like peptide-1 receptor agonists reduce the risk of decompensation in patients with type 2 diabetes across different stages of liver disease. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Huerta, A, Brujats, A, Alvarado-Tapias, E, Pons, M, Téllez, L, Ojeda, A, Aracil, C, Amezcua, AG, Torres, F, Garcia-Pagán, JC, Albillos, A, Genesca, J, Escorsell, A, Bosch, J, Villanueva, C. Long-term outcomes of compensated cirrhosis with mild portal hypertension. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Galvez, CM, Blanco-Colio, L, Picatoste, B, Ortega-Villanueva, L, Mendez-Barbero, N, Oller-Pedrosa, J, Escola-Gil, JC, Bellis, S, Rabinovich, G, Martin-Ventura, JL. Myeloid-specific ST6Gal1 deficiency favours atherosclerotic progression. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.157. PMID:. IF:13.300(Q1/1D).

Alen, A, Muñoz, C, Soriano-Amores, M, de Frutos, F, Báez-Ferrer, N, Peña-Peña, ML, Villacorta, E, Ripoll-Vera, T, Zorio, E, Martínez-Gimeno, A, Bermúdez-Jiménez, J, Limeres, J, Tiron, C, Martínez-Alvarez, E, Cabrera-Romero, E, García-Pavía, P, Espinosa, MA, Piqueras, J, García-Hernández, S, Palomino-Doza, J, Moliner-Abós, C, Moris, G, Carrillo-Mora, LM, Syrris, P, Alvarez-Velasco, R, Gimeno, JR, Lorca, R. Sex Differences in Cardiac Involvement in Adults With Myotonic Dystrophy Type 1 A Multicenter Study. JACC-ADVANCES. 2026; 5(5)DOI:10.1016/j.jacadv.2026.102771. PMID:42202377. IF:(Q/D).

Martinez, GG, Padro, T, Guala, A, Fernandez, R, Garcia-Elias, A, Borrell-Pages, M, Olivero, R, Martin-Grieve, S, Badimon, L, Maceira, A, Rodriguez-Palomares, JF, Vilahur, G. HDL structural and compositional alterations in type 2 diabetes mellitus patients: identifying potential biomarkers for subclinical atherosclerosis detection and disease progression. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.071. PMID:. IF:13.300(Q1/1D).

Chavez, REE, De Isla, LPP, Casanas, MC, Romero, MJR, Badimon, LB, Vilahur, GV, Mata, PM, Padro, TP. MicroRNA changes in plasma associated with fibrous coronary plaque remodelling after PCSK9 inhibitor therapy in familial hypercholesterolemia with subclinical atherosclerosis. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.002. PMID:. IF:13.300(Q1/1D).

Urgell, AC, Garcia, O, Pena, E, Vilahur, G, Marques, GA. Long-term tissue factor expression orchestrates the angiogenic potential of adipose derived stem cells through par smad signaling and activin a cooperation. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.136. PMID:. IF:13.300(Q1/1D).

Dababneh, SF, Claydon, TW, Shafaattalab, S, Prondzynski, M, Kashihara, H, Hove-Madsen, L, Sanatani, S. In Memoriam: Glen F. PhD. CANADIAN JOURNAL OF CARDIOLOGY. 2026; 42(5)DOI:10.1016/j.cjca.2026.03.002. PMID:41796860. IF:5.300(Q1/2D).

Romero-Gómez, M, Escalada, J, Noguerol, M, Pérez, A, Carretero, J, Crespo, J, Mascort, JJ, Aguilar, I, Tinahone, F, Cañones, P, Gómez-Huelgas, R, de Luis, D, Trullos, IG, Aller, R, Rubio, MA, Calleja, JL. Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis (vol 48, 502442. 2025). Gastroenterologia y Hepatologia. 2026; 49(5)DOI:10.1016/j.gastrohep.2025.502639. PMID:41571546. IF:1.900(Q3/7D).

Younossi, ZM, Yu, ML, de Avila, L, Petta, S, Hagström, H, Kim, SU, Nakajima, A, Crespo, J, Castera, L, Alkhouri, N, Zheng, MH, Treeprasertsuk, S, Ananchuensook, P, Shalimar, S, Tsochatzis, E, Shenoy, KT, Mohan, L, Fan, JG, Roberts, S, Alswat, KA, Wong, VWS, Yilmaz, Y, Dunn, W, Francque, S, Cordie, A, Alqahtani, S, Ekstedt, M, Goh, GBB, Oliveira, CP, Pessoa, M, Chan, WK, Fernández, MIC, Duseja, AK, Arab, JP, Papatheodoridis, G, Sebastiani, G, Villela-Nogueira, CA, D'Ambrosio, R, Lampertico, P, Al Naamani, K, Holleboom, AG, Valsan, A, Venu, A, El-Kassas, M, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Caussy, C, Pearlman, B, Iruzubieta, P, Nadeem, R, Cinque, F, Papatheodoridi, M, Zoncape, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Teh, KKJ, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Pugliese, N, Vessby, J, Xie, CC, Choudhary, NS, Friend, E, Poca, M, Kawaguchi, T, Russo, FP, Gadano, A, Diaz, LA, Singal, AK, Ségrestin, B, Gunn, N, Mauricio, D, Arrese, M, Fracanzani, AL, Lombardi, R, Aghemo, A, Zelber-Sagi, S, Lam, B, Racila, A, Stepanova, M. Liver fibrosis is the only predictor of adverse outcomes: time to remove metabolic dysfunction associated steatohepatitis (MASH) resolution as a clinical trial endpoint. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Ampuero, J, Crespo, J, Maya-Miles, D, Ibañez-Samaniego, L, Panero, JLC, Graupera, I, Jiménez-Massip, A, Aller, R, Gómez-Camarero, J, Benlloch, S, Martin-Mateos, R, Morillas, RM, Gallego-Durán, R, Bernal, V, Turnes, J, Sanchez, MD, Poca, M, Martínez, RL, Escudero-García, D, Lo Iacono, O, Olveira, A, Francés, R, Iruzubieta, P, Lopez, LS, Esteban, JR, Soria, A, Pericàs, JM, Romero-Gómez, M. Clinical significance of patients with significant fibrosis missed by the EASL algorithm in metabolic-associated steatotic liver disease: findings from the HEPAMET registry. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Maya-Miles, D, Aller, R, Crespo, J, Ibañez-Samaniego, L, González, A, Pericàs, JM, Sanchez, MD, Escudero-Garcia, D, Rosales-Zábal, JM, Benlloch, S, Gómez-Camarero, J, Diez, R, Pavon-Castillero, E, Graupera, I, Latorre, R, Morillas, RM, Panero, JLC, Turnes, J, Aspichueta, P, Gallego-Durán, R, Francés, R, Martin-Mateos, R, Bernal, V, Poca, M, Olveira, A, Rodriguez, CF, Andrade, RJ, Carnicero, C, Iruzubieta, P, Lopez, LS, Fuertes-Yebra, E, Jiménez-Massip, A, Romero-Gómez, M, Ampuero, J. The body roundness index as a novel anthropometric marker in metabolic-associated steatotic liver disease: findings from the HEPAMET registry. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Bertot, LC, Roberts, S, Ampuero, J, Crespo, J, Iruzubieta, P, Maya-Miles, D, Carrillo-Fernández, P, Kemp, W, Mohamedashrafali, MAAC, Teoh, B, Ibañez-Samaniego, L, Lopez, LS, Sigüenza, R, Arroyo-López, V, Esteban, JR, Guerra, JA, Romero-Gómez, M, Camarero, JG, Albillos, A, Poca, M, Andrade, RJ, Ortiz, JPT, Sanchez, MD, George, J, Wallace, M, Aller, R, Adams, L. Optimizing hepatocellular cancer surveillance in metabolic dysfunction-associated steatotic liver disease based on liver stiffness measurement. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Lázaro, DR, Jiménez-Massip, A, El Maimouni, C, Canillas, L, Vergara, M, Poca, M, Rodríguez-Castellano, A, Munoz, EE, Serra, I, Pagès, L, Carrión, J, Soria, A, Mas, E, Morillas, RM, Ginès, P, Graupera, I, Broquetas, T, Pericàs, JM. Social determinants of health are associated with the risk of hepatic and cardiovascular events in patients with advanced MASLD: prediction using the novel LiverSocial score. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Ivancovsky-Wajcman, D, Villota-Rivas, M, Manolas, M, Villas-Riotorto, V, Arora, A, Brennan, PN, Mauricio, D, Leith, D, Willemse, J, Betel, M, Alnaser, F, El Kassas, M, Lazarus, J. Healthcare provider perspectives on mental health in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: the role of multidisciplinary teams and sex differences. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Ivancovsky-Wajcman, D, Villota-Rivas, M, Manolas, M, Villas-Riotorto, V, Arora, A, Brennan, PN, Mauricio, D, Leith, D, Willemse, J, Betel, M, Alnaser, F, El Kassas, M, Lazarus, J. Factors influencing mental health care provision for people with metabolic dysfunction-associated steatotic liver disease and steatohepatitis. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Romero-Gómez, M, Escalada, J, Noguerol, M, Pérez, A, Carretero, J, Crespo, J, Mascort, JJ, Aguilar, I, Tinahones, F, Cañones, P, Gómez-Huelgas, R, de Luis, D, Trullos, IG, Aller, R, Rubio, MA, Calleja, JL. Multidisciplinary clinical practice guidelines for the management of metabolic fatty liver disease. Gastroenterologia y Hepatologia. 2026; 49(5)DOI:10.1016/j.gastrohep.2025.502640. PMID:. IF:1.900(Q3/7D).

Diamantopoulos, L, Kalligeros, M, Isaacs, SD, Mauricio, D. Association of Metabolic Dysfunction-Associated Steatohepatitis with Metabolic-Related Diseases Diabetes, Prediabetes, and Obesity. Clinics in Liver Disease. 2026; 30(2)DOI:10.1016/j.cld.2025.12.001. PMID:42142893. IF:4.100(Q1/3D).

Milad, C, Mesa, A. The echo of a question, ten years later: Letter to Amanda and Jesus. Endocrinologia Diabetes y Nutricion. 2026; 73(5)DOI:10.1016/j.endien.2026.501772. PMID:41887969. IF:1.800(Q3/8D).

Hong, CZ, Ballester, MP, Perricone, G, Merli, M, Buti, M, Panero, JLC, Soriano, G, Toniutto, P, Ampuero, J, Russo, FP, Sacerdoti, D, Coenraad, M, Berenguer, M, Piano, S, Sangiovanni, A, Albillos, A, Gander, A, Patel, VC, Caraceni, P, Wright, G, Iruzubieta, P, Andrade, RJ, Garcia-Samaniego, FJ, Verhelst, X, Uson, E, Sanchez-Garrido, C, Mehta, G, Jalan, R. Serological responses COVID-19 vaccination: a potential biomarker to predict liver-related complications in patients with compensated advanced liver disease (cACLD). JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

El Maimouni, C, Jiménez-Massip, A, Canillas, L, Serra, I, Vergara, M, Morillas, RM, Poca, M, Broquetas, T, Rodríguez-Castellano, A, Munoz, EE, Soria, A, Pages, L, Carrión, J, Casas, M, Ardevol, A, Rojo, D, Alonso, N, Julián, MT, Bassegoda, O, Gines, P, Pericàs, JM, Graupera, I. Assessment of cardiometabolic comorbidities and the impact of glycemic and weight control on liver stiffness in advanced metabolic dysfunction-associated steatotic liver disease. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Juanola, A, Moreta, MJ, Solé, C, Perez-Guasch, M, Gratacós-Ginès, J, Soria, A, Cuyàs, B, Martin-Llahi, M, Ma, A, Pompili, E, Fernández, I, Amorós, M, Cruceta, A, Diestro, S, Domenech, G, Rios, J, Sánchez, J, Fabrellas, N, Graupera, I, Pose, E, Ginès, P. Treatment with albumin improves circulatory function in patients with cirrhosis and hypovolemic hyponatremia: insights from a randomized controlled trial, the ALBUCAT study. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Biswas, S, Aggarwal, A, Lo, GH, Luo, XF, Yang, L, Escorsell, A, Mehta, S, Swaroop, S, Agarwal, S, Agarwal, A, Mishra, A, Tripathi, S, Gunjan, D, Gamangatti, S, Shalimar. Efficacy and safety of endoscopic and endovascular interventions for secondary prophylaxis of gastric varices in patients with cirrhosis: systematic review and individual patient data meta-analysis. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Canillas, L, Jimenez-Esquivel, N, Amador, A, Brujats, A, Sánchez, J, Pelegrina, A, Pardo, C, Montaña, SH, Fajol, MC, de Sárraga, C, Alvarez, J, Duran, X, Burdio, F, Reverter, E, Carrión, JA. Predictive model of postoperative mortality in patients with cirrhosis. Surgical risk score for patients with cirrhosis (S-RISC). JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Salomone, F, Gil-Gómez, A, Barreca, F, Longo, M, Soriano, G, Francés, R, Gallego-Durán, R, Herrojo, JA, Tafani, M, Dongiovanni, P, Romero-Gómez, M. SIRT5 rs12216101 T > G variant is associated with hepatic encephalopathy and impaired ammonia metabolism in patients with cirrhosis. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Fernández-Aguilera, M, Calvo-Orteu, M, Aparicio, AP, Carrión, JA, de Miera, IS, Vergara, M, Poca, M, Canga, E, Ardevol, A, Ariza, X, Amador, A, Sáez-Peñataro, J, Forns, X, Barciela, MR. Rechallenge after a DILI episode: importance of the pattern and the medication class. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).